Latest Insider Transactions at Gilead Sciences, Inc. (GILD)
This section provides a real-time view of insider transactions for Gilead Sciences, Inc. (GILD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GILEAD SCIENCES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GILEAD SCIENCES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 09
2022
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,416
+15.59%
|
$404,208
$63.91 P/Share
|
|
Nov 01
2022
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Open market or private sale
|
Direct |
16,255
-36.46%
|
$1,284,145
$79.25 P/Share
|
|
Nov 01
2022
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,255
+26.72%
|
$1,170,360
$72.7 P/Share
|
|
Sep 10
2022
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
458
-1.13%
|
$29,770
$65.28 P/Share
|
|
Sep 10
2022
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
990
+2.39%
|
-
|
|
Sep 10
2022
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,528
-0.6%
|
$99,320
$65.28 P/Share
|
|
Sep 10
2022
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,301
+1.28%
|
-
|
|
Sep 10
2022
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
481
-1.11%
|
$31,265
$65.28 P/Share
|
|
Sep 10
2022
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,039
+2.35%
|
-
|
|
Sep 10
2022
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
148
-0.52%
|
$9,620
$65.28 P/Share
|
|
Sep 10
2022
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
318
+1.1%
|
-
|
|
Sep 10
2022
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
476
-0.7%
|
$30,940
$65.28 P/Share
|
|
Sep 10
2022
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,027
+1.49%
|
-
|
|
Aug 10
2022
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,066
-3.65%
|
$67,158
$63.14 P/Share
|
|
Aug 10
2022
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,479
+7.82%
|
-
|
|
Jul 24
2022
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,206
-7.53%
|
$192,360
$60.8 P/Share
|
|
Jul 24
2022
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,505
+14.99%
|
-
|
|
Jun 10
2022
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
485
-1.14%
|
$29,100
$60.74 P/Share
|
|
Jun 10
2022
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,039
+2.38%
|
-
|
|
Jun 10
2022
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,539
-0.61%
|
$92,340
$60.74 P/Share
|
|
Jun 10
2022
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,300
+1.29%
|
-
|
|
Jun 10
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
280
-0.83%
|
$16,800
$60.74 P/Share
|
|
Jun 10
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
782
+2.27%
|
-
|
|
Jun 10
2022
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
148
-0.55%
|
$8,880
$60.74 P/Share
|
|
Jun 10
2022
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
317
+1.16%
|
-
|
|
Jun 10
2022
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-1.3%
|
$27,720
$60.74 P/Share
|
|
Jun 10
2022
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
990
+2.71%
|
-
|
|
Jun 10
2022
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,969
-2.85%
|
$118,140
$60.74 P/Share
|
|
Jun 10
2022
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,672
+3.28%
|
-
|
|
May 05
2022
|
Harish Manwani Director |
SELL
Payment of exercise price or tax liability
|
Direct |
477
-4.78%
|
$29,097
$61.35 P/Share
|
|
May 05
2022
|
Harish Manwani Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,444
+19.68%
|
-
|
|
May 05
2022
|
Anthony Welters Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,444
+28.82%
|
-
|
|
May 05
2022
|
Javier Rodriguez Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,444
+27.31%
|
-
|
|
May 05
2022
|
Kevin E Lofton Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,444
+2.5%
|
-
|
|
May 05
2022
|
Jeffrey Bluestone Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,444
+29.98%
|
-
|
|
May 05
2022
|
Jacqueline K Barton Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,444
+10.73%
|
-
|
|
May 03
2022
|
Anthony Welters Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,223
+38.24%
|
-
|
|
May 03
2022
|
Javier Rodriguez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,223
+35.38%
|
-
|
|
May 03
2022
|
Kevin E Lofton Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,223
+2.34%
|
-
|
|
May 03
2022
|
Harish Manwani Director |
SELL
Payment of exercise price or tax liability
|
Direct |
349
-4.43%
|
$20,940
$60.33 P/Share
|
|
May 03
2022
|
Harish Manwani Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,223
+22.01%
|
-
|
|
May 03
2022
|
Sandra Horning Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,112
+38.94%
|
-
|
|
May 03
2022
|
Jeffrey Bluestone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,223
+40.51%
|
-
|
|
May 03
2022
|
Jacqueline K Barton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,223
+11.05%
|
-
|
|
Apr 28
2022
|
Kevin E Lofton Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
16,322
+15.28%
|
$408,050
$25.62 P/Share
|
|
Mar 11
2022
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
SELL
Open market or private sale
|
Direct |
3,634
-10.04%
|
$210,772
$58.24 P/Share
|
|
Mar 10
2022
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,602
-5.33%
|
$205,314
$57.92 P/Share
|
|
Mar 10
2022
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,901
+3.84%
|
-
|
|
Mar 10
2022
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,221
-8.53%
|
$183,597
$57.92 P/Share
|
|
Mar 10
2022
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,987
+8.85%
|
-
|